BPIFrance Investissement SAS invested in TargEDys SA
Mar 25, 2017 - RelSci Data Update
Investments

Background Information:
BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France.The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.
In The News:
BPIFrance Investissement SAS invested in ATR Ingénierie SAS
November 12, 2017  •  RelSci
BPIFrance Investissement SAS invested in VeriCampus, Inc.
April 14, 2017  •  RelSci
Actility Energised by $75M of New Capital to Accelerate Industrial IoT Solutions Globally
April 12, 2017  •  Business Wire
BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France.The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.
TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.
In The News:
TargEDys grabs funding
April 11, 2017  •  peHUB
TargEDys Extends Series A and Appoints New Board Members
April 11, 2017  •  PR Newswire
TargEDys Develops New Microbiome-based Solutions for Appetite Regulation and Announces a (EURO)5.8M International Round of Financing to Demonstrate Product Clinical Efficacy
April 14, 2016  •  PR Newswire
TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.